Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
March 2021
Digital Magazine
Archives
Subscription
Features
Update on the Safety and Efficacy of Oral Anticoagulation in CKD and ESRD
Analgesia and Sedation Strategies in COVID-19 Patients
Challenges in Managing and Preventing Rheumatoid Arthritis Pain
CYP2C9 Polymorphism and Use of Oral Nonsteroidal Anti-Inflammatory Drugs
Pharmacologic Management of Cancer-Related Pain
Ramsay Hunt Syndrome and the Pharmacist
Treatment Approaches for Fibromyalgia
Update on the Safety and Efficacy of Oral Anticoagulation in CKD and ESRD
Departments
Consult Your Pharmacist
Chronic Kidney Disease
Contemporary Compounding
Ketamine Hydrochloride 10%, Gabapentin 10%, and Ketoprofen 10% in Lipoderm
Editorial
Opioid-Use Policies Causing Unintended Consequences
TrendWatch
Prescription Opioid Use During Pregnancy
X
April 2024
In This Issue
Digital Magazine
Archives
Subscription
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
• April 2026
• 2.00 Credits
Managing HIV Coinfections and Complications
Pain Management
• March 2026
• 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
Cardiovascular
• February 2026
• 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
×
Full Image